Answers are grounded in this paper and cite their sources.
Network pharmacology reveals improved clinical efficacy and antithrombotic action in polycythemia vera patients with blood stasis syndrome.
Network pharmacology predicted the corresponding targets of traditional Chinese medicine to a certain extent. Huoxue Jiedu prescription could enhance clinical efficacy, improve hematological indicators, and reduce coagulation indicators through antithrombotic effect by inhibiting the expression of PI3K and AKT1.
No takes yet. Share an insight, caveat, or question.
Yu-min et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: